TGFB1 and Alzheimer disease: In contrast, it was reported that rescuing TGF-β signaling could alleviate the pathological injury like Aβ deposition in AD, which was intended to be a potential therapeutic target of AD (Town et al., 2008; Caraci et al., 2018).